Despite rising costs driven partly by AI investment, the large law firm sector is posting another year of robust financial performance across key metrics. New findings from the Citi Global Wealth at
Doceree has unveiled Semmelweis, a proprietary artificial intelligence reasoning and orchestration model built exclusively for pharmaceutical commercialisation and marketing. The model serves as the intelligence layer powering Daily Command, Doceree’s newly launched
MoreA federal judge has found that a lawsuit brought by President Trump against the IRS sought to “manipulate the judicial process,” resulting in sanctions against attorneys involved. The controversy centres on an
MoreThe FTSE 100 (^FTSE) closed higher on Tuesday as incoming Chancellor John Healey pledged fiscal control and defence stocks posted strong gains. The FTSE 100 finished up 61.15 points, or 0.6%, at
MoreMitie Group (MTO.L) shares soared on Thursday after the facilities management company confirmed it had agreed to a buyout deal, lifting broader UK markets. The announcement sent Mitie’s stock sharply higher, making
MoreSanofi has unveiled a revised executive lineup set to take effect on 1 September, as newly installed CEO Belén Garijo moves to reshape leadership across the organisation. Garijo, a former CEO of
MorePresident Donald Trump signed three proclamations on July 20, 2026, imposing additional 50% duties on specified Canadian goods covering motor vehicles, alcoholic beverages and dairy products. The tariffs mark the first-ever use
MoreDefence stocks received a notable lift on the FTSE 100 as investors reacted positively to new Prime Minister Andy Burnham’s appointment of John Healey as Chancellor of the Exchequer. BAE Systems (LSE:
MoreMitie Group (MTO), the FTSE 250 facilities management company, has agreed to a £3.1 billion takeover by rival firm OCS Group in a significant deal reshaping the sector. The acquisition brings together
MoreAmgen has agreed to a $74 million settlement to resolve a class action lawsuit alleging the biotechnology giant withheld critical tax liability information from investors for far too long. The preliminary settlement
MoreIndia’s pharmaceutical and healthcare regulatory landscape continued to evolve significantly during the first half of 2026, with authorities introducing a range of new measures and frameworks. The changes were aimed at simplifying
More
